Botanical species · safety record
Dichroa febrifuga
The EFSA Compendium of Botanicals holds 13 constituent measurements for Dichroa febrifuga. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Dichroa febrifuga Lour.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 4 licensed products naming Dichroa febrifuga as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Alkaloids4
- Febrifugine3
- Isofebrifugine2
- Berberine1
- Coumarins1
- Lectins1
- Quinazolin-4-ol1
Plant parts
- Leaves7
- Unspecified4
- Roots and other underground parts2
Preparations
- Solvent extraction1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Alkaloids | Roots and other underground parts | — | ≥ 0.02 Percent | — | No resolvable identifier |
| Alkaloids | Roots and other underground parts | — | ≤ 0.05 Percent | — | No resolvable identifier |
| Alkaloids | Leaves | — | ≥ 0.5 Percent | — | No resolvable identifier |
| Alkaloids | Leaves | — | ≤ 0.7 Percent | — | No resolvable identifier |
| Berberine | Unspecified | — | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Coumarins | Unspecified | — | — | — | No resolvable identifier |
| Febrifugine | Leaves | — | ≤ 0.19 Percent | — | No resolvable identifier |
| Febrifugine | Leaves | — | ≥ 0.15 Percent | — | No resolvable identifier |
| Febrifugine | Unspecified | — | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Isofebrifugine | Leaves | — | ≥ 0.5 Percent | — | No resolvable identifier |
| Isofebrifugine | Leaves | — | ≤ 0.7 Percent | — | No resolvable identifier |
| Lectins | Leaves | Solvent extraction | — | Unspecified | No resolvable identifier |
| Quinazolin-4-ol | Unspecified | — | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Zabolotnaya, E. S., Safronich, L. N. Alkaloids from Dichroa febrifuga introduced into the USSR. Trudy vsesoyuznogo nauchno-issledovatel'skogo instituta lekarstvennykh rastenii, 1969, p. 356-361.
- Zheng, Changwen., Xiao, Xiao., Wang, Yongli. Purification and characterization of the lectin from Dichroa febrifuga Lour (DFL). Shengwu huaxue zazhi, 1988, p. 12-20.
- Zhang, Ya., Li, Chun., Lei, Guo-lian. Study on chemical components of Dichroa febrifuga Lour. Zhongguo shiyan fangjixue zazhi, 2010, p. 40-42.
- Li, Yan., Liu, Ming-chuan., Jin, Lin-hong., Hu, De-yu., Yang, Song. Advances on chemical components and bioactivities of Dichroa febrifuga Lour.. Guangzhou huagong, 2011, p. 7-9.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.